← Open Payments lookup

EMANPREET KAUR: Open Payments

NPI 1104693506 · GRANDVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,555 in 70 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,204 · 2025 $1,555

Food & beverage: $1,555
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$324
Vanda Pharmaceuticals Inc.7$183
Alkermes, Inc.10$173
Lundbeck LLC5$160
Teva Pharmaceuticals USA, Inc.8$157
Supernus Pharmaceuticals, Inc.8$145
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$98
ABBVIE INC.5$89
Axsome Therapeutics, Inc.3$84
Otsuka America Pharmaceutical, Inc.4$83

Products named: INGREZZA, REXULTI, FANAPT, ARISTADA, Qelbree, UZEDY, CAPLYTA, Auvelity.

Industry payments across MI — which companies pay providers there.